Sandu Pharmaceuticals35.71
+0.04 (-2.96%)

Sandu Pharmaceuticals Share Price

35.71+0.04 (-2.96%)
-10.75% past 1 Year

Corporate filings & documents

Announcements

Newspaper publication in respect of Unaudited Financials for the Q and Half Year ended 30th September 2026
6 days ago
statement of deviation and variation of funds for q ended 30th sept 2026
1 week ago
Results for Q and half year ended 30th sept 2026
1 week ago
Outcome of the Board Meeting dated 14th November 2026
1 week ago
Newspaper Publication for opening of special widow for re-lodgment of transfer requests for physical shares
1 week ago
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Approval of Unaudited Financials for Q and half year ended 30th September 2026
2 weeks ago
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Approval of Unaudited Financials for Q and half year ended 30th September 2026
2 weeks ago
Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta
1 month ago
Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta
1 month ago
compliance certificate under Reg 74(5) of SEBI(DP) Regulation for Q ended 30th September 2026
1 month ago
compliance certificate under Reg 74(5) of SEBI(DP) Regulation for Q ended 30th September 2026
1 month ago
Intimation to the holders of Physical Securities to furnish PAN and KYC details
1 month ago
Intimation to the holders of Physical Securities to furnish PAN and KYC details
1 month ago
Intimation about closure of trading window for Quarter ended 30th September 2026
2 months ago
Intimation about closure of trading window for Quarter ended 30th September 2026
2 months ago
1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company.2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director
2 months ago
1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company.2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director
2 months ago
Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting
2 months ago
Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting
2 months ago
41st Annual General Meeting scrutinizers Report
2 months ago
41st Annual General Meeting scrutinizers Report
2 months ago
Proceedings of the 41st Annual General Meeting held on Friday 11th september 2026 at 04:30 pm
2 months ago
Proceedings of the 41st Annual General Meeting held on Friday 11th september 2026 at 04:30 pm
2 months ago
Newspaper Publication opening of special window for re-lodgement of transfer request for physical shares
2 months ago
Newspaper Publication opening of special window for re-lodgement of transfer request for physical shares
2 months ago
Newspaper Advertisement intimating shareholders about Notice of Annual General Meeting and Evoting
3 months ago
Newspaper Advertisement intimating shareholders about Notice of Annual General Meeting and Evoting
3 months ago
Letters to shareholders on annual report weblink whose email ids are not registered with the company/RTA
3 months ago
Letters to shareholders on annual report weblink whose email ids are not registered with the company/RTA
3 months ago
41st Annual Report of Sandu Pharmaceuticals Limited
3 months ago
41st Annual Report of Sandu Pharmaceuticals Limited
3 months ago
Intimation about Annual General Meeting
3 months ago
Intimation about Annual General Meeting
3 months ago
Newspaper Advertisement Pre despatch of Annual Report intimation to Shareholders
3 months ago
Newspaper Advertisement Pre despatch of Annual Report intimation to Shareholders
3 months ago
Newspaper Publication Unaudited Financials for Q ended 30th June 2026
3 months ago
Newspaper Publication Unaudited Financials for Q ended 30th June 2026
3 months ago
approval of material related party transactions subject to approval of shareholder
3 months ago
approval of material related party transactions subject to approval of shareholder
3 months ago
statement of deviation and utlisation of funds for q ended 30.06.2026
3 months ago
statement of deviation and utlisation of funds for q ended 30.06.2026
3 months ago
Appointment of M/s Dave & Dave Chartered Accountant as statutory auditor subject to approval of the shareholder
3 months ago
Appointment of M/s Dave & Dave Chartered Accountant as statutory auditor subject to approval of the shareholder
3 months ago
Intimation about the date of the annual General Meeting
3 months ago
Intimation about the date of the annual General Meeting
3 months ago
Intimation about the Record date
3 months ago
Intimation about the Record date
3 months ago
Intimation about Book closure for AGM
3 months ago
Intimation about Book closure for AGM
3 months ago
Outcome and results of the Board Meeting dated 11.08.2026
3 months ago

Concalls & investor presentations

Empty box

No presentations found

Sandu Pharmaceuticals Ltd Share Price Today

The Sandu Pharmaceuticals Ltd share price today is ₹35.32. During the trading session, the Sandu Pharmaceuticals Ltd share price opened at ₹36.8 and recorded an intraday high of ₹36.8 and a low of ₹35.3. Last closing price was ₹36.2. Over the past 52 weeks, the Sandu Pharmaceuticals Ltd share price has ranged between ₹30 and ₹50. The current Sandu Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.